Decoy Therapeutics Inc. Cash and Restricted Cash
Decoy Therapeutics Inc. (DCOY) had Cash and Restricted Cash of $8.29 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-12
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8.29M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7.82M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $10.71M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.81M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $8.29M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $7.82M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $10.71M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $4.81M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $794.89K 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $1.80M 10-Q · filed 2026-05-08 | |
| 2024-12-31 | $2.43M 10-Q · filed 2026-08-12 | |
| 2024-09-30 | $3.28M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $3.27M 10-Q · filed 2025-08-12 | |
| 2024-03-31 | $4.37M 10-Q · filed 2025-05-14 | |
| 2023-12-31 | $5.90M 10-K · filed 2026-03-31 | |
| 2023-09-30 | $7.58M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $11.54M 10-Q · filed 2024-08-09 | |
| 2023-03-31 | $9.27M 10-Q · filed 2024-05-13 | |
| 2022-12-31 | $12.11M 10-K · filed 2025-03-21 | |
| 2022-09-30 | $16.82M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $22.65M 10-Q · filed 2023-08-10 | |
| 2022-03-31 | $24.19M 10-Q · filed 2023-05-11 | |
| 2021-12-31 | $29.21M 10-K · filed 2024-03-22 | |
| 2021-09-30 | $31.90M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $33.08M 10-Q · filed 2022-08-05 | |
| 2021-03-31 | $36.61M 10-Q · filed 2022-05-12 | |
| 2020-12-31 | $11.12M 10-K · filed 2023-03-27 | |
| 2020-09-30 | $9.56M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $7.22M 10-Q · filed 2021-08-05 | |
| 2020-03-31 | $9.65M 10-Q · filed 2021-05-12 | |
| 2019-12-31 | $3.74M 10-K · filed 2022-03-25 | |
| 2019-09-30 | $4.00M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $4.14M 10-Q · filed 2020-08-12 | $6.51M 10-Q · filed 2019-07-17 |
| 2019-03-31 | $5.77M 10-Q/A · filed 2020-05-15 | $7.30M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $6.13M 10-K · filed 2021-03-18 | $9.96M 10-K · filed 2019-03-06 |
| 2018-09-30 | $6.05M 10-Q · filed 2019-11-12 | $13.09M 10-Q · filed 2018-11-05 |
| 2018-06-30 | $15.88M 10-Q · filed 2019-07-17 | |
| 2018-03-31 | $22.07M 10-Q · filed 2019-05-01 | |
| 2017-12-31 | $519.34K 10-K · filed 2020-03-23 | $19.31M 10-Q · filed 2018-05-02 |
| 2017-09-30 | $20.41M 10-Q · filed 2018-11-05 | |
| 2017-06-30 | $39.25M 10-Q · filed 2018-08-01 | |
| 2017-03-31 | $21.20M 10-Q · filed 2018-05-02 | |
| 2016-12-31 | $22.54M 10-K · filed 2019-03-06 | |
| 2015-12-31 | $66.81M 10-K · filed 2019-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |